Early detection. Proactive intervention. 70% Central Venous Catheter
Edwards oximetry central venous catheter (CVC) the first proven CVC with continuous monitoring reveals the true adequacy of tissue oxygenation for clarity in early assessment and intervention. 1 10 Edwards oximetry central venous catheter continuously monitors central venous oxygen saturation ( ), an early indicator of compromised or inadequate oxygen delivery. 6 10 monitoring Proactive management of tissue hypoxia 6 10 Hemodynamic trends ECG MAP CVP SpO 2 150 100 90 90 60 30 10 5 0 100 75 50 25 By providing a more sensitive indicator of oxygen imbalance, Edwards oximetry central venous catheter identifies critical changes earlier than traditional vital signs and intermittent sampling enabling you to recognize and prevent tissue hypoxia sooner. 6 10 0 Hour 1.5 Hours 3 Hours Helps guide therapy and provide real-time insight into the efficacy of intervention. 6,7 Demonstrated prognostic value of continuous monitoring. 11 Post-op high-risk surgeries 12 Trauma 9 Sepsis 13 Cardiac failure in congenital heart failure 10 Recovery in cardiac arrest 14 15 monitoring has multiple applications in intra- and post-op stages: 16,17 Risk for high blood loss, such as hepatic resections, trauma, vascular cases High fluid shifts in gastrointestinal cases Toleration of single-lung ventilation in thoracic procedures Early indication of failure to tolerate extubation
The advantages of antimicrobial protection and high-pressure injection, together in a single device. 18,19 Oligon integrated antimicrobial protection Integrated Oligon antimicrobial material provides enduring antimicrobial protection that will not wash away like antimicrobial coatings. Silver ions (Ag+) are released at a stable rate to attack microbes, alter cell DNA and disrupt cell reproduction. The resulting long-term release of silver into lumens and subcutaneous spaces protects against gram-negative and gram-positive bacteria, fungi and resistant microorganism strains. 18,19,20 High-pressure injection capability Edwards oximetry central venous catheter is indicated for high-pressure injection of contrast media for visualization under imaging modalities such as CT, MRI and fluoroscopy. 18 For Oligon models only. CO Vasoactive medications Inotropic medications Dysrhythmia Congestive heart failure Shock SaO 2 Hypoxia/hypoxemia Suctioning, atelectasis Ventilation/oxygenation Lung disease Hb Hemorrhage Occult bleeding Anemia Hemodilution VO 2 Sepsis Work of breathing Fever, shivering Pain/anxiety monitoring reveals the root cause of oxygen imbalance, allowing you to determine appropriate therapy. 6,21 Convenient, accurate and easy to use. 6,17,22 Edwards oximetry central venous catheter provides: Simplicity and flexibility uses the same insertion techniques as central lines 22 monitoring, pressure monitoring and fluid resuscitation 2,18 Accurate oxygenation status 2,4 Central Venous Catheter with Integrated Oligon Antimicrobial Protection Central Venous Catheter
See clearly. Stay ahead. References inserted above Designed for use with Edwards monitoring platforms, Edwards oximetry central venous catheters offer the clarity of an early warning to support early intervention. Central Venous Catheter with Integrated Oligon Antimicrobial Protection Early assessment with real-time monitoring enables you to make proactive clinical decisions for your high-risk patients. 6,7 Edwards EV1000 Clinical Platform Presents patient physiologic status in an intuitive, meaningful way to clinically support proactive hemodynamic management. PediaSat Oximetry Catheter The first and only pediatric oximetry catheter with continuous monitoring to help you stay ahead of hypoxia and stages of sepsis. 11,23 25 Edwards oximetry central venous catheter Lumens Length (CM) Oligon Region X3816KT 3 16 US X3820KT 3 20 US XA3816KT 3 16 X US XA3816SAFKT 3 16 X US XA3820KT 3 20 X US XA3820SAFKT 3 20 X US For over 40 years, Edwards Lifesciences has been helping you make proactive clinical decisions to advance the care of surgical and critical care patients. Through ongoing collaboration with you, ongoing education and our never-ending quest for advancement, Edwards develops solutions that provide the clarity to make proactive clinical decisions. Know more. Visit Edwards.com/OximetryCVC CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events. Edwards, Edwards Lifesciences, the stylized E logo, EV1000, PediaSat, and PreSep are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners. 2016 Edwards Lifesciences Corporation. All rights reserved. PP--US-1378 Edwards Lifesciences One Edwards Way, Irvine CA 92614 USA edwards.com
References for Edwards oximetry central venous catheter brochure 1. Central Venous Catheter Instructions for Use 2. Clinical PreSep PediaSat Clinical Evaluation Report. 3. FDA 510k K053609 4. FDA 510k K061585 5. FDA 510k K091786 6. Reinhart K, et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med. 2004;30(8):1572-8. 7. Rivers EP, et al. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care. 2001;7(3):204-11. 8. Ingelmo P, et al. Importance of monitoring in high risk surgical patients. Minerva Anestesiol. 2002;68(4):226-30. 9. Scalea, TM, et al. Central venous oxygen saturation: a useful clinical tool in trauma patients. J Trauma 1990;30(12):1539-43. 10. Ander, DS, et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol 1998;82(7):888-91. 11. Spenceley, N., et al. Continuous central venous saturations during pericardial tamponade case report. Pediatr Crit Care Med 2007,Vol. 8,No. 3,p18.2.153. 12. Pearse, R, et al. Changes in central venous saturation after major surgery, and association with outcome. Crit Care 2005;9(6):R694-91. 13. Rady, MY, et al. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. Am J Emerg Med 1996;14(2):218-25. 14. Rivers, EP, et al. The clinical implications of continuous central venous oxygen saturation during human CPR. Ann Emerg Med 1992;21(9):1094-101. 15. Nakazawa, K, et al. Usefulness of central venous oxygen saturation monitoring during cardiopulmonary resuscitation. A comparative case study with endtidal carbon dioxide monitoring. Intensive Care Med 1994;20(6):450-1. 16. Noguiera P, et al. Central Venous Saturation: A Prognostic Tool in Cardiac Surgery Patients. J Intensive Care Med. 2010;25(2):111-116. 17. Vallet B, et al. Venous oxygen saturation as a physiologic transfusion trigger. Crit Care. 2010;14:213. 18. FDA 510k Central Venous Catheter (K160645) 19. US Patent #4411648 20. Edwards Oligon Oximetry Catheters contain an integrated Oligon antimicrobial material. The activity of the antimicrobial agent is localized at the catheter surfaces and is not intended for treatment of systemic infections. In vitro testing demonstrated that the Oligon material provided broad-spectrum effectiveness ( 3 log reduction from initial concentration within 48 hours) against the organisms tested: Staphylococcus aureus, Staphylococcus epidermidis, Klebsiella pneumoniae, Enterococcus faecalis, Candida albicans, Escherichia coli, Serratia marcescens, Acinetobacter calcoaceticus, Corynebacterium diphtheriae, Enterobacter aerogenes, GMRSa, Pseudomonas aeruginosa, Candida glabrata and VRE (Enterococcus faecium). 21. Zaja J. Venous oximetry. Signa Vitae 2007;2(1):6-10. 22. Mahajan A, et al. An experimental and clinical evaluation of a novel central venous catheter with integrated oximetry for pediatric patients undergoing cardiac surgery. Pediatric Central Venous Oximetry. Anest Anal. 2007;Vol.105, No. 6, 1598. 23. Krahn, G., et al. Early clinical evaluation of the Edwards PediaSat oximetry catheter in pediatric patients. Pediatr Crit Care Med 2007,Vol. 8,No. 3,p18.2.152. 24. Spenceley, N., et al. Continuous central venous saturation monitoring in pediatrics: a case report. Pediatr Crit Care Med 2008, Vol. 9, No. 2, p e13-e16 25. Lemson et al. Advanced hemodynamic monitoring in critically ill patients. Pediatrics. 2011. CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events. Edwards, Edwards Lifesciences, the stylized E logo, PediaSat, and PreSep are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners. 2016 Edwards Lifesciences Corporation. All rights reserved. PP--US-1378 Edwards Lifesciences One Edwards Way, Irvine CA 92614 USA edwards.com